Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-06-11DOI: 10.1080/15504263.2026.2676698
Mohammad Alabbas, Yuqi Guo, Jingyi Shi, Hongke Wu, Walaa Mahmoud, Shreya Sengupta, Omar T Sims
{"title":"Concurrent Alcohol Use and Smoking Among US Adults with Hepatitis C.","authors":"Mohammad Alabbas, Yuqi Guo, Jingyi Shi, Hongke Wu, Walaa Mahmoud, Shreya Sengupta, Omar T Sims","doi":"10.1080/15504263.2026.2676698","DOIUrl":"10.1080/15504263.2026.2676698","url":null,"abstract":"<p><strong>Objective: </strong>Concurrent alcohol use and smoking exert super-additive toxic effects that accelerate hepatic injury in people living with hepatitis C (HCV). Objectives of this study were to estimate the prevalence of concurrent alcohol use and active smoking at the population-level over the last decade among adults living with HCV in the United States (U.S.), examine trends in the prevalence of concurrent alcohol use and active smoking, and to identify risk factors associated with concurrent alcohol use and active smoking.</p><p><strong>Methods: </strong>We conducted a repeated cross-sectional analysis using six NHANES cycles (2007-2018). The study population included adults aged ≥20 years with current HCV infection, defined as detectable HCV RNA with confirmatory anti-HCV seropositivity, and complete data on alcohol use and smoking status. Analyses incorporated NHANES' complex survey design (strata, primary sampling units, and MEC examination weights). Prevalence estimates and temporal trends were derived using design-based methods, with linear regression applied to test for trends. Associations were examined using design-adjusted multinomial logistic regression to calculate adjusted odds ratios (aORs).</p><p><strong>Results: </strong>The pooled, survey-weighted prevalence of concurrent alcohol use and active smoking among adults living with HCV in the U.S. between 2007 and 2018 was 39.5%. Trends in the prevalence of concurrent alcohol use and active smoking did not decrease but instead remained relatively high over the 11-year period (Trend P = 0.71). In multivariate analysis, current marijuana use (aOR = 2.88, 95% CI 2.84-2.92), lifetime substance use (aOR = 5.98, 95% CI 5.87-6.10), depression (aOR = 2.59, 95% CI 2.55-2.63), and a history of cancer (aOR = 1.50, 95% CI 1.45-1.54) were positively associated with concurrent alcohol use and active smoking.</p><p><strong>Conclusions: </strong>Markedly high and non-decreasing rates of concurrent alcohol use and active smoking at the population-level may contribute to higher incident cases of HCV-related morbidity and mortality in the near future.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"277-286"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148220072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-06-22DOI: 10.1080/15504263.2026.2676701
Sufyan Shahid, Hamza Saeed, Uzair Majeed, Hasnain Wajeeh Saqib, Muhammad Ibrahim Shah, Minahil Iqbal, Akhil Anand
{"title":"Suicide-Related Mortality Among Individuals with Mental and Behavioral Disorders Due to Psychoactive Substance Use: A 25-Year U.S. Nationwide Analysis (1999-2023).","authors":"Sufyan Shahid, Hamza Saeed, Uzair Majeed, Hasnain Wajeeh Saqib, Muhammad Ibrahim Shah, Minahil Iqbal, Akhil Anand","doi":"10.1080/15504263.2026.2676701","DOIUrl":"10.1080/15504263.2026.2676701","url":null,"abstract":"<p><p><b>Objective:</b> Mental and behavioral disorders due to psychoactive substance use, as defined by ICD-10 codes F10-F19, include a spectrum of substance use disorders such as acute intoxication, withdrawal, harmful use, and dependence related to alcohol, opioids, stimulants, cannabis, tobacco, and other substances. These conditions significantly increase the risk of suicide, yet national trends in suicide-related mortality among affected individuals remain underexplored. This study aimed to evaluate national trends in suicide and self-harm mortality among individuals with these disorders from 1999 to 2023. <b>Methods:</b> We conducted a retrospective analysis of U.S. death certificate data from the CDC Wide-ranging Online Data for Epidemiologic Research (WONDER) database (1999-2023). Decedents with mental and behavioral disorders due to psychoactive substance use were identified using ICD-10 codes F10-F19, encompassing acute intoxication, withdrawal, harmful use, and dependence. Suicide and self-harm deaths were defined by ICD-10 codes U03, X60-X84, and Y87. Age-adjusted mortality rates (AAMRs) per million and average annual percentage changes (AAPCs) were estimated using Joinpoint regression. Analyses were stratified by sex, age, race/ethnicity, and metropolitan status. <b>Results:</b> Between 1999 and 2023, 37,473 suicide-related deaths were identified among U.S. individuals with mental and behavioral disorders due to psychoactive substance use. AAMRs increased from 2.2 to 5.7 per million (AAPC: 3.31; <i>p <</i> .01). Males had higher mortality than females (6.6 vs. 2.9), though females had a steeper rate of increase over time. Middle-aged adults had the highest AAMR (8.2), followed by younger (6.9), older adults (3.4) and children and adolescents (1.1). Non-Hispanic (NH) American Indian/Alaska Native individuals (AI/AN) had the highest AAMR (13.5), followed by NH White (6.2), Hispanic/Latino (1.6), NH Black (1.6), and NH Asian/Pacific Islander (API) (1.4). From 1999 to 2000, non-metropolitan areas had higher AAMRs than metropolitan areas (6.5 vs. 4.3), with significant increases in both settings. <b>Conclusions:</b> Suicide-related mortality among individuals with mental and behavioral disorders due to psychoactive substance use has increased significantly increased in the United States from 1999 to 2023, demonstrating substantial disparities by sex, age, race/ethnicity, and geographic region. These findings highlight the critical need for integrated approaches in suicide prevention and substance-related treatment settings.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"236-244"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148303353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-06-22DOI: 10.1080/15504263.2026.2675226
Julia Thomas, Kevin Wenzel, Jennifer Carrano, Marc Fishman
{"title":"Inconsistent Self-Reports of Lifetime Suicide Attempts During Residential Treatment for Opioid Use Disorder.","authors":"Julia Thomas, Kevin Wenzel, Jennifer Carrano, Marc Fishman","doi":"10.1080/15504263.2026.2675226","DOIUrl":"10.1080/15504263.2026.2675226","url":null,"abstract":"<p><p><b>Objective:</b> Individuals with opioid use disorder (OUD) are disproportionately at risk for suicide. Residential OUD treatment programs routinely assess suicide risk factors. However, the degree to which patients consistently self report lifetime suicide attempts (LSAs) on these measures is unknown. Using patient data from electronic health records, we examined the prevalence of self-reported LSAs, consistency of reporting on assessment measures within one treatment episode and across multiple episodes, and predictors of consistent reporting. <b>Methods:</b> Our sample consisted of all patient records for residential OUD treatment from 12/01/2020- 11/30/2021 with data on LSAs (<i>N</i> = 1,206). Three self-report assessments conducted by clinical staff during the treatment episodes measured LSAs. <b>Results:</b> LSAs were reported during 22% of residential treatment episodes on at least one measure. Within one treatment episode, 13% of individuals inconsistently self-reported LSAs across the different measures, and across multiple episodes, 23%. Those who were younger, female, identified as LGB, endorsed co-occurring anxiety or depressive symptoms and reported lifetime intravenous opioid use were more likely to inconsistently self report LSAs. <b>Conclusions:</b> These results suggest that single administration self-report instruments may be insufficient to adequately assess LSAs in patients with OUD. Care should be taken to assess suicide in this population that is already at increased risk.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"205-213"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148302985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-07-10DOI: 10.1080/15504263.2026.2686088
Catherine Comiskey, David McDonagh, Sonam Prakashini Banka-Cullen, Philip James, Sadie Lavelle Cafferkey, Jessica Eustace-Cook
{"title":"Systematic Review and Meta-Analysis of Attention Deficit Hyperactivity Disorder: First Estimates of the Prevalence by Sex Amongst People Who Use Psychoactive Substances and Alcohol.","authors":"Catherine Comiskey, David McDonagh, Sonam Prakashini Banka-Cullen, Philip James, Sadie Lavelle Cafferkey, Jessica Eustace-Cook","doi":"10.1080/15504263.2026.2686088","DOIUrl":"10.1080/15504263.2026.2686088","url":null,"abstract":"<p><p><b>Objective:</b> The World Health Organization describes neurodevelopmental disorders as behavioral and cognitive disorders that occur during a baby's developmental period: these include autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) amongst others. The original aim of this study was to provide estimates of the prevalence of ADHD and ASD by sex and by substance used amongst people who engage with services for drug and alcohol use. This study ultimately focused on people who use substances, are attending treatment and support services and have ADHD symptoms. <b>Methods:</b> A systematic review and meta-analysis were conducted within acute hospitals, community and prison healthcare settings. All participants were adults over the age of 18. Measurements included a diagnosis of ADHD or ASD, defined as having used a suitable tool to diagnose in childhood including a current adult assessment or diagnosis. <b>Results:</b> A total of 84 studies and 99 estimates were included forming a combined sample of 34,036 individuals. A prevalence rate of 22%, 95% CI [19, 25] was found. A significant heterogeneity in studies was detected. Only one paper reported on ASD and a meta-analysis of the prevalence of ASD was not feasible. The highest ADHD prevalence rates were found amongst people using cannabis 33%, 95% CI [28, 39]. This was significantly higher than the overall prevalence rate. The same rate of 33%, 95% CI [23, 44%] was found among women using benzodiazepines. The highest rate amongst males was also found amongst those using benzodiazepines 31%, 95% CI [23, 44%]. The lowest prevalence rate at 5%, 95% CI [1, 11] was found among women using cocaine and this was also significant. Rates amongst those using opioids was 27%, 95% CI [20, 36] for women and 24%, 95% CI [19, 30] for men. These estimates had low or moderate heterogeneity. <b>Conclusions:</b> Rates of ADHD can vary greatly between sex and choice of substance used. It is essential that the international consensus documents on treatment for, and training in ADHD symptom management are implemented to ensure an evidence informed approach to service delivery.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"265-276"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148425585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-06-11DOI: 10.1080/15504263.2026.2676697
Samantha J Meckes, Jeremy Grove, Jaclyn C Kearns, Jonathan W Miao, Zoe Bridges-Curry, Jack D Wiese, Nathan A Kimbrel, Patrick S Calhoun
{"title":"Psychiatric Outcomes and Treatment Utilization Among Post-9/11 Veterans with PTSD: The Impact of Current and Remitted Substance Use Disorders.","authors":"Samantha J Meckes, Jeremy Grove, Jaclyn C Kearns, Jonathan W Miao, Zoe Bridges-Curry, Jack D Wiese, Nathan A Kimbrel, Patrick S Calhoun","doi":"10.1080/15504263.2026.2676697","DOIUrl":"10.1080/15504263.2026.2676697","url":null,"abstract":"<p><p><b>Objective:</b> U.S. veterans experience comorbid posttraumatic stress disorder and substance use disorders (PTSD-SUD) at high rates, resulting in poorer psychosocial outcomes when compared to the effects of either condition alone. However, it is unclear how veterans with PTSD and a current or remitted SUD compare to those with PTSD alone. <b>Methods:</b> This study compared post-9/11 era veterans with PTSD only, PTSD + current SUD, and PTSD + remitted SUD on psychological outcomes and treatment history. <b>Results:</b> Veterans with PTSD + current SUD reported greater suicidality, PTSD symptom severity, and psychiatric distress, compared to those with PTSD only and PTSD + remitted SUD. Veterans with PTSD only and PTSD + remitted SUD reported comparable symptom levels. <b>Conclusions:</b> Findings highlight that the combination of PTSD and a current SUD is a potential risk factor for suicidality. Enhancing the effectiveness of and access to PTSD-SUD interventions may be an important pathway to suicide risk reduction.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"245-257"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148220064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-07-10DOI: 10.1080/15504263.2026.2686086
Rodrigo Marín-Navarrete, Ricardo Sánchez-Domínguez, Carmen Fernández-Cáceres, Ricardo Saracco-Álvarez
{"title":"Medical Symptoms and Psychiatric Comorbidities in People with Methamphetamine Use Disorder.","authors":"Rodrigo Marín-Navarrete, Ricardo Sánchez-Domínguez, Carmen Fernández-Cáceres, Ricardo Saracco-Álvarez","doi":"10.1080/15504263.2026.2686086","DOIUrl":"10.1080/15504263.2026.2686086","url":null,"abstract":"<p><p>Long-term methamphetamine use is associated with health problems such as chest pain, cardiac complications, hypertension, and gastric problems. It also leads to mental health issues such as hallucinations, anxiety and depressive disorders, psychosis, and paranoia.</p><p><strong>Objective: </strong>Characterize and identify the medical symptoms and psychiatric comorbidities reported by people with methamphetamine use disorder (MUD).</p><p><strong>Methods: </strong>Secondary database analysis using information on physical and mental health problems obtained during history taking from 2014 to 2021. A total of 208,764 patients with medical records, all those who met the diagnosis of MUD were selected, analyzing a sample of 8,713 people with MUD.</p><p><strong>Results: </strong>Tobacco (85.8%), alcohol (68.1%), and marijuana (31.2%) were used in the past month. Anxiety (25.2%), depressive (23.9%), and psychotic (11.3%) disorders were the most prevalent disorders, with tachycardia (10.1%), gastritis (9.8%), depression (16.7%), anxiety (13.3%), insomnia (12.1%), psychosis (13.6%), myalgia (7.8%) and dyspnea (6.4%) being the most frequently reported conditions.</p><p><strong>Conclusions: </strong>Methamphetamine use is associated with a range of medical and psychiatric conditions, creating problems that require multidisciplinary care to address the complications arising from its use.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"191-204"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148425589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-06-11DOI: 10.1080/15504263.2026.2676699
Sean T Lynch, John J Mariani, Frances R Levin
{"title":"Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity.","authors":"Sean T Lynch, John J Mariani, Frances R Levin","doi":"10.1080/15504263.2026.2676699","DOIUrl":"10.1080/15504263.2026.2676699","url":null,"abstract":"<p><p><b>Objective:</b> Substance use disorders (SUDs) frequently co-occur with serious mental illness (SMI) and remain undertreated, in part due to limited pharmacologic options for many substances. Dopamine receptor-modulating agents (DRMAs), particularly antipsychotics with partial agonist activity, have been investigated for their potential to influence craving, reward processing, and relapse. This commentary reviews the evolving evidence for dopamine receptor modulation in SUDs, with particular emphasis on second-generation antipsychotics (SGAs) and the D3-preferring partial agonist cariprazine. <b>Methods:</b> A narrative review of preclinical, clinical, and observational literature was conducted, focusing on dopamine receptor antagonists and partial agonists studied in populations with SUDs, including individuals with co-occurring SMI. Particular attention was given to pharmacologic mechanisms involving D2 versus D3 receptor activity and to emerging evidence regarding cariprazine. <b>Results:</b> Early studies of first-generation antipsychotics, characterized by potent and sustained D2 receptor antagonism, generally demonstrated limited benefit or worsening of substance use outcomes. SGAs have shown more heterogeneous effects, likely reflecting variability in receptor-binding profiles and study methodologies. Increasing evidence highlights the role of the dopamine D3 receptor in substance-related motivation, reward, and cue reactivity. Cariprazine, the only currently approved antipsychotic with high affinity and preferential activity at the D3 receptor, has demonstrated potential benefits across preclinical models, case reports, and observational studies. Reported improvements include reductions in substance use, craving, and relapse-particularly for stimulant and cannabis use disorders-alongside improvements in psychiatric symptoms and functioning. However, most clinical evidence remains limited to small samples, non-randomized designs, and variable outcome measures. <b>Conclusions:</b> Dopamine receptor modulation, particularly targeting the D3 receptor, represents a promising but still emerging strategy for the treatment of SUDs, especially in individuals with co-occurring psychiatric disorders. Cariprazine's unique pharmacologic profile and broad clinical indications position it as a compelling candidate for further investigation. Rigorous randomized controlled trials using standardized substance use outcomes are needed to clarify its efficacy and role in integrated treatment models for dual diagnosis populations.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"258-264"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13537437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148220117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefania Chiappini, Valerio Ricci, Sergio De Filippis, Diego Quattrone, Giovanni Martinotti
{"title":"Current Practices in the Treatment of Dual Diagnosis: Insights from a Nationwide Survey of Italian Psychiatrists on Pharmacological and Nonpharmacological Approaches, Challenges, and Limitations.","authors":"Stefania Chiappini, Valerio Ricci, Sergio De Filippis, Diego Quattrone, Giovanni Martinotti","doi":"10.1080/15504263.2026.2686094","DOIUrl":"10.1080/15504263.2026.2686094","url":null,"abstract":"<p><p><b>Objective:</b> This study investigated current clinical practices, organizational barriers, and resource availability in managing dual diagnosis (co-occurring psychiatric and substance use disorders) among Italian psychiatrists in a healthcare system characterized by service fragmentation between mental health and addiction care. <b>Methods:</b> A structured, self-administered online questionnaire was distributed nationwide to Italian psychiatrists. The survey covered demographic characteristics; organizational aspects and service collaboration; pharmacological and nonpharmacological approaches; and perceived clinical challenges. Data were analyzed descriptively to identify practice patterns and priority intervention areas. <b>Results:</b> Seventy-nine psychiatrists participated from diverse settings (38% addiction services, 25% community mental health services, 14% hospitals, 15% other facilities). While 78% regularly treated dual diagnosis patients, only 38% reported structured protocols between mental health and addiction services. Collaboration was rated as only partially effective by 44%. Integrated treatment was preferred by 61%. The most commonly prescribed medications included mood stabilizers (94%), atypical antipsychotics (68%), anticraving agents (54%), and antidepressants (37%). For depression, trazodone (32%) and serotonergic antidepressants (25%) were used most. For psychosis, aripiprazole (47%) was predominant. Most clinicians (81%) combined pharmacotherapy with psychosocial interventions. Key barriers included insufficient training (67% highlighted need for specialized clinicians), poor service integration, and diagnostic uncertainty. <b>Conclusions:</b> Significant gaps persist in Italian dual diagnosis care despite clinical awareness. Urgent priorities include routine screening, clinician training, national guideline development, organizational reforms promoting service collaboration, and increased availability of structural resources, which was reported as insufficient by 61% of respondents. These improvements are essential for delivering timely, evidence-based, integrated care to this vulnerable population.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"287-303"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148362659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of Dual DiagnosisPub Date : 2026-07-01Epub Date: 2026-06-11DOI: 10.1080/15504263.2026.2686091
Diana Ho, Dominique N Sheldon, Jewelia J Ferguson, Catherine D Trinh, Ateka A Contractor, Prachi H Bhuptani, Ceren Günsoy, Nicole H Weiss
{"title":"The Role of Emotional Avoidance in the Relation Between Posttraumatic Stress Disorder Symptoms and Alcohol Use and Related Harm Amongst Asian American Adults.","authors":"Diana Ho, Dominique N Sheldon, Jewelia J Ferguson, Catherine D Trinh, Ateka A Contractor, Prachi H Bhuptani, Ceren Günsoy, Nicole H Weiss","doi":"10.1080/15504263.2026.2686091","DOIUrl":"10.1080/15504263.2026.2686091","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the current study was to investigate relations between posttraumatic (PTSD) symptom severity, negative and positive emotional avoidance, and alcohol use and related harm amongst an adult community sample of Asian Americans.</p><p><strong>Methods: </strong>An adult sample of Asian Americans (<i>N</i> = 105, 67.6% women) participated in a study examining emotional experiences, including negative and positive emotional avoidance, PTSD symptom severity, and alcohol use and related harm, across different racial and ethnic groups.</p><p><strong>Results: </strong>There was a significant indirect effect of PTSD symptom severity on alcohol use and related harm through the pathway of positive (<i>β</i> = -0.02, 95% CI [-0.10, 0.02]), but not negative emotional avoidance (<i>β</i> = 0.10, 95% CI [0.02, 0.19]).</p><p><strong>Conclusions: </strong>The current study builds upon emerging evidence for the critical role of positive emotional experiences in the co-occurrence of PTSD and alcohol use and related harm in an underrepresented population of Asian Americans. Findings suggest that amongst Asian Americans, positive emotional avoidance may play a key role in the association between PTSD and alcohol use and related harm. Thus, it may be beneficial to address positive emotional avoidance in interventions aimed at reducing alcohol use and related harm amongst Asian Americans experiencing PTSD symptoms.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"214-225"},"PeriodicalIF":1.5,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148220135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}